UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
NNN REIT
NNN
$8.94B
| $12.8M | 0.01% |
311,880
-53,156
| -15% | -$2.2M |
|
777
iShares MSCI EAFE ETF
EFA
$79.4B
| $12.8M | 0.01% |
198,733
-418,700
| -68% | -$26.4M |
|
778
Douglas Emmett
DEI
$1.93B
| $12.7M | 0.01% |
427,231
-157,408
| -27% | -$4.58M |
|
779
Acadia Healthcare
ACHC
$2.86B
| $12.7M | 0.01% |
176,780
-3,115
| -2% | -$200K |
|
780
Core Laboratories
CLB
$513M
| $12.5M | 0.01% |
119,469
-1,762
| -1% | -$188K |
|
781
Lear
LEA
$7.93B
| $12.4M | 0.01% |
112,054
+21,555
| +24% | +$2.26M |
|
|
CBL
782
DELISTED
CBL& Associates Properties, Inc.
CBL
| $12.4M | 0.01% |
626,592
-29,387
| -4% | -$592K |
|
|
PLKI
783
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $12.4M | 0.01% |
206,899
-4,400
| -2% | -$262K |
|
784
Wolfspeed
WOLF
$1.43B
| $12.2M | 0.01% |
344,772
-2,837
| -0.8% | -$102K |
|
|
IMPV
785
DELISTED
Imperva, Inc.
IMPV
| $12.2M | 0.01% |
286,542
-2,861
| -1% | -$127K |
|
786
iShares MSCI South Korea ETF
EWY
$23.8B
| $12.2M | 0.01% |
213,468
+26,806
| +14% | +$1.51M |
|
787
Albemarle
ALB
$14.8B
| $12.2M | 0.01% |
230,194
-200,755
| -47% | -$11M |
|
788
Eagle Materials
EXP
$6.48B
| $12.1M | 0.01% |
145,240
+19,567
| +16% | +$1.52M |
|
|
SRC
789
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $12.1M | 0.01% |
223,914
-13,849
| -6% | -$766K |
|
|
RLYP
790
DELISTED
RELYPSA INC COM
RLYP
| $12.1M | 0.01% |
336,200
+7,800
| +2% | +$281K |
|
791
Carter's
CRI
$1.48B
| $12.1M | 0.01% |
131,112
+20,066
| +18% | +$1.73M |
|
792
Landstar System
LSTR
$6.01B
| $12M | 0.01% |
181,318
-349
| -0.2% | -$23.6K |
|
|
RYL
793
DELISTED
RYLAND GROUP INC
RYL
| $12M | 0.01% |
245,860
+380
| +0.2% | +$16.3K |
|
|
HNT
794
DELISTED
HEALTH NET INC
HNT
| $11.9M | 0.01% |
196,866
+51,024
| +35% | +$2.87M |
|
795
Kinross Gold
KGC
$30.4B
| $11.9M | 0.01% |
5,361,114
-137,711
| -3% | -$401K |
|
|
EGN
796
DELISTED
Energen
EGN
| $11.9M | 0.01% |
180,048
-1,812
| -1% | -$117K |
|
797
Extra Space Storage
EXR
$31.6B
| $11.8M | 0.01% |
174,966
-13,425
| -7% | -$881K |
|
798
Fossil Group
FOSL
$344M
| $11.8M | 0.01% |
143,386
-75,795
| -35% | -$6.97M |
|
|
QEP
799
DELISTED
QEP RESOURCES, INC.
QEP
| $11.8M | 0.01% |
564,604
-22,009
| -4% | -$460K |
|
800
Goodyear
GT
$1.94B
| $11.7M | 0.01% |
432,833
-25,664
| -6% | -$671K |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.